CLINICAL TRIALS PROFILE FOR ULTRALENTE INSULIN
✉ Email this page to a colleague
All Clinical Trials for ULTRALENTE INSULIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00222521 ↗ | Insulin Glargine Vs Standard Insulin Therapy | Completed | Moran, Antoinette, M.D. | Phase 3 | 2003-04-01 | This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin. |
NCT00222521 ↗ | Insulin Glargine Vs Standard Insulin Therapy | Completed | Sanofi | Phase 3 | 2003-04-01 | This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin. |
NCT00222521 ↗ | Insulin Glargine Vs Standard Insulin Therapy | Completed | University of Minnesota | Phase 3 | 2003-04-01 | This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ULTRALENTE INSULIN
Condition Name
Clinical Trial Locations for ULTRALENTE INSULIN
Trials by Country
Clinical Trial Progress for ULTRALENTE INSULIN
Clinical Trial Phase
Clinical Trial Sponsors for ULTRALENTE INSULIN
Sponsor Name